RE: Disappointing, but what comes next?1 Oct 2021 18:45
Synairgen are an AIM company and with the fortunes of the company riding on the success of the trials you can understand the price fluctuations. Again I will repeat a previous post though, based on number this drug is cheap as you are not giving it to everyone like the vaccine.
I continue to believe based on all data to date that this will become a FTSE company or be brought out, anyone investing thinking this would be a smooth ride shouldn't be investing.
There is interest here from large funds and they invest to make money, hold your investment and enjoy the rollercoaster ride, you will eventually enjoy it :-)